Article Details

Stelis Biopharma's CDMO partner receives USFDA approval for a key ANDA

Retrieved on: 2022-12-28 09:16:30

Tags for this article:

Click the tags to see associated articles and topics

Stelis Biopharma's CDMO partner receives USFDA approval for a key ANDA. View article details on hiswai:

Excerpt

Stelis Biopharma, the biologics arm of Strides Pharma Science announced ... The filing for the product was done from Stelis Biopharma's flagship ...

Article found on: www.business-standard.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up